News & Media – Lee's Pharmaceutical
20 DEC 2018

Auransa Enters into Exclusive Licensing Agreement with China Oncology Focus Limited, an Affiliate of Lee’s Pharmaceutical Holdings, for Rights to AU018 in Greater China and Southeast Asia

PALO ALTO, CA, AND HONG KONG – December 19, 2018 – Auransa, Inc., an artificialintelligence (AI)-driven pharmaceutical company developing precision medicines in areas ofsignificant unmet medical need……



News & Media

News & Media

21/10/2019

Pre-IND meeting to communicate the combination of recombinant fully...

04/09/2019

Zhaoke (Guangzhou)Oncology Pharmaceutical Ltd.had a very successful...

20/08/2019

INOMAX pre-NDA meeting

02/04/2019

RegeneRx and Lee’s Pharm to Accelerate RGN-259 Development in China

20/12/2018

Auransa Enters into Exclusive Licensing Agreement with China Oncology...

06/09/2018

SillaJen and Lee’s Pharmaceutical Announce First Patient Enrolled in...

14/02/2018

GC Pharma and Lee’s Pharm Enter into China Licensing Agreement to...

08/02/2018

CHINA ONCOLOGY FOCUS LIMITED RECEIVES APPROVAL BY CHINESE AUTHORITIES...

22/11/2017

Eleison Pharmaceuticals to Partner with China Oncology Focus Limited,...

21/11/2017

Shenogen Pharma and Lee’s Pharm entered into a Collaboration...

02/11/2017

Windtree and Lee’s Pharm Close $10 Million Share Purchase Agreement...

04/10/2017

Appointment Of Ms. Zhang Zhen Hua, Ada As Group Director Of Human...

21/08/2017

Zingo® for Needle-free Local Analgesia is approved by Hong Kong...

26/07/2017

SillaJen and Lee’s Pharmaceutical Announce Approval by the China CFDA...

29/06/2017

Adapalene and Clindamycin combination hydrochloride Gel meets...

13/06/2017

Windtree Therapeutics and Lee’s Pharmaceutical (HK) Limited Enter...

09/03/2017

China FDA has Approved Zingo® for Pediatric Use Needle-free Local...

27/02/2017

05/01/2017

Dilaforinitiates phase IIb clinical trial with tafoxiparin in women...

05/01/2017

TOT BIOPHARM and LEE’S PHARM Signed an Exclusive Licensing Agreement...

03/01/2017

First patient enrolled in Registration Studyof Natulan® forpatients...

02/12/2016

CVieTherapeutics Enrolled the First Patient in Phase 2b Clinical...

14/11/2016

Submitted New Drug Application to China FDA and Hong Kong DHon ...

07/10/2016

Kato Pharmaceuticals, Inc. and Lee’s Pharmaceutical Holdings Limited...

27/09/2016

Dilafor raises SEK 51 million to facilitate Phase IIb clinical study...

09/09/2016

Completed The First Subject in Clinical Study for Continuous Glucose...

25/08/2016

Beijing Shenogen Pharma Group Limited and Lee’s Pharmaceutical (HK)...

04/07/2016

China FDA Grants Pharmaceutical Manufacturing License to Nansha...

16/06/2016

Lee’s Pharm Announces its Chief Executive Officer, Dr. Benjamin...

02/06/2016

RegeneRx and Lee’s Pharm Announce Acceleration of RGN-259 Development...

16/05/2016

APPOINTMENT OF DR. LIT-FUI LAU AS PRESIDENT AND CHIEF OPERATING...

14/04/2016

14/04/2016

14/04/2016

14/04/2016

14/04/2016

14/04/2016

14/04/2016

24/03/2016

24/03/2016

24/03/2016

24/03/2016

U.S. FDA Grants Orphan Drug Designation to Anfibatide for Treatment...

14/03/2016

Successful FDA Inspection with No 483 Issued to Powder Pharmaceuticals

23/02/2016

23/02/2016

23/02/2016

23/02/2016

23/02/2016

23/02/2016

23/02/2016

23/02/2016

23/02/2016

23/02/2016

04/01/2016

Salvat and Lee’s Pharmaceutical (HK) Limited Announce Exclusive...

31/12/2015

31/12/2015

31/12/2015

31/12/2015

31/12/2015

31/12/2015

31/12/2015

31/12/2015

31/12/2015

31/12/2015

31/12/2015

31/12/2015

31/12/2015

31/12/2015

22/12/2015

CVie Therapeutics enrolled the 1st patient for Phase 2b Clinical...

08/12/2015

Lee’s Pharm was honored at 2015’s Forbes Asia “Best Under A Billion”...

08/12/2015

Lee’s Pharm Announces its Chief Executive Officer, Dr. Benjamin Li...

25/11/2015

Solasia and Lee’s Pharma Announce License, Promotion and Supply...

17/11/2015

Tragara and Lee’s Pharma Enter into Exclusive Licensing...

28/10/2015

First Patient enrolled in Phase IIb Clinical Trial of Anfibatide in...

22/09/2015

Armetheon and Lee’s Pharma Enter into Agreement to Develop and...

11/09/2015

Recently Published Study Shows Positive Results for ZiNGO® in...

26/08/2015

WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing...

24/08/2015

BioQuiddity and Lee’s Pharmaceutical Enter Agreement to Jointly...

03/08/2015

CVIE Therapeutics obtained approval from the Ministry of Health and...

03/07/2015

Presentation at The First Chinese Symposium of Thrombosis and...

30/03/2015

First patient enrolled in Phase Ib-IIa clinical studyof Adapalene and...

09/03/2015

Lee’s Pharm Joins Hang Seng Broad Consumption Index, Hang Seng...

26/02/2015

Lee’s Zhaoke Pharmaceutical Ranks Second in 2014 for Number of...

27/11/2014

EyeSense Attracts Lee’s Pharmaceutical Holdings as Strategic Investor

19/11/2014

Ikaria and Lee’s Pharmaceutical Announce Strategic Partnership for...

12/11/2014

Patients Enrollment Completed in Phase II Clinical Study of...

12/11/2014

Lee’s Pharmaceutical successfully obtained the Imported Drug License...

10/11/2014

Lee’s Pharm Becomes a Constituent Stock of MSCI China Index under...

06/10/2014

SORRENTO AND LEE’S PHARMACEUTICAL ENTER INTO EXCLUSIVE CHINA...

01/10/2014

01/10/2014

01/10/2014

01/10/2014

08/09/2014

License, Distribution and Supply Agreement to market Cholecalciferol...

01/09/2014

01/09/2014

01/09/2014

01/09/2014

01/09/2014

01/09/2014

01/08/2014

01/08/2014

01/08/2014

01/08/2014

01/07/2014

01/07/2014

01/07/2014

23/06/2014

Chinese FDA Accepts Phase 2 IND for RGN-259 for Dry Eye

01/06/2014

01/06/2014

09/05/2014

ScinoPharm and Lees Pharmaceutical Jointly Develop a Number of Drug...

01/05/2014

01/05/2014

01/05/2014

01/05/2014

01/05/2014

01/05/2014

01/05/2014

01/05/2014

16/04/2014

License, Distribution and Supply Agreement to market Neridronic Acid...

01/04/2014

01/04/2014

03/03/2014

Powder Pharmaceuticals Hong Kong made the first shipment to US

01/03/2014

27/02/2014

ZHAOKE New Facility in Hefei Received GMP Approval by CFDA

20/02/2014

Dilafor enters into a license and partnership agreement with Lee’s...

01/01/2014

01/01/2014

01/01/2014

01/01/2014

01/01/2014

25/11/2013

Execution of License, Distribution & Supply Agreement for Zingo®...

01/11/2013

01/11/2013

01/11/2013

01/11/2013

01/11/2013

01/11/2013

01/11/2013

01/11/2013

01/11/2013

03/10/2013

First Patient Enrolled in Phase II Clinical Study of Istaroxime in...

02/10/2013

Lee’s Pharm announces that China registration study of Trazodone...

04/09/2013

Jennerex and Lee’s Pharm announces that its phase 2 study of Pexa-Vec...

28/08/2013

Clinical Trial Application to Conduct Phase III APEX Study of...

06/08/2013

Clinical Trial Application for Phase III study for Gimatecan was...

01/08/2013

Powder Pharmaceuticals Hong Kong as the Manufacturing Site for...

24/07/2013

Lee’s Present Positive Anfibatide Phase I and II Clinical Data ...

15/07/2013

Obtained Imported Drug License for Levocarnitine Oral Solution in...

10/07/2013

First Patient Enrolled in Phase III Clinical Trial of Prulifloxacin...

09/07/2013

Powder Pharmaceuticals Hong Kong Manufacturing Facility is Acceptable...

01/07/2013

01/07/2013

01/07/2013

01/07/2013

01/07/2013

01/07/2013

01/07/2013

27/06/2013

Patients Enrollment Completed in Clinical Study on Trazodone...

13/06/2013

First Patient Enrolled in Phase IIb Clinical Trial of Rostafuroxin in...

03/06/2013

Submitted Clinical Study Application to the CFDA for Istaroxime in...

22/05/2013

Jennerex and Lee’s Pharmaceutical Announce Completion of Enrollment...

16/04/2013

Lee’s Pharmaceuticals Announces it has Obtained the Imported Drug...

09/04/2013

Powder Pharmaceuticals Appointed Two Members to Join the Board of...

01/04/2013

26/02/2013

Jennerex and Lee’s Pharmaceutical Announce Expansion of Partnership...

13/02/2013

Jennerex Announces Nature Medicine Publication Highlighting...

13/02/2013

Jennerex Announces Cancer Research Publication Demonstrating Vascular...

08/02/2013

Dyax Corp. and CVie Therapeutics Announce Partnership to Develop and...

29/01/2013

Portola and Lee’s Pharmaceutical Enter into Agreement to Expand ...

14/12/2012

License and Supply Agreement signed to market Leuprolide in China,...

01/12/2012

01/12/2012

01/12/2012

01/12/2012

01/12/2012

01/12/2012

01/12/2012

22/11/2012

Lee’s Pharmaceutical Announces First Patient Treated in Phase 2b...

02/11/2012

Powder Pharmaceuticals made submission to US FDA for approval of Hong...

29/10/2012

A newspaper article reported at The Standard, “There is no cure for...

25/10/2012

Lee’s Pharmaceutical Appoints Dr. Giuseppe Bianchi to as Chief...

08/10/2012

Lee’s Pharmaceutical Appoint Dr. Lit-Fui Lau to its Senior Management...

01/09/2012

01/09/2012

01/09/2012

01/09/2012

01/09/2012

01/09/2012

01/09/2012

01/09/2012

31/08/2012

Lee’s Pharm wins the Technological Achievement Award in the 2012...

28/08/2012

08/08/2012

Issuance of shares by CVie Therapeutics and Phase IIb Clinical...

06/08/2012

First patient enrolled in Phase Ib-IIa clinical study of Anfibatide...

17/07/2012

RegeneRx and Lee’s Pharmaceutical Complete License Agreement for ...

11/07/2012

Phase III clinical study of L-Carnitine on chronic Heart Failure...

01/06/2012

01/06/2012

01/06/2012

01/06/2012

10/04/2012

Lee’s Pharmaceutical licenses GI safer aspirin product for China from...

21/03/2012

Jennerex and Lee’s Pharmaceutical Announces First Patient Treated in...

14/03/2012

Obtained Medical Device Registration Certificateof Hyalofemme® from...

01/03/2012

01/03/2012

06/02/2012

MAJOR MILESTONE ACHIEVEMENT IN AN ASSOCIATED COMPANY

01/12/2011

01/12/2011

30/11/2011

Jennerex and Lee’s Pharmaceutical Presents Final Data From...

22/11/2011

Lee’s Pharm was honored at 2011’s Forbes Asia “Best Under A Billion”...

07/11/2011

Jennerex and Lee’s Pharmaceutical Announces First Patient...

12/09/2011

Submitted New Drug Application to the SFDA on Remodulin For Treatment...

09/09/2011

Jennerex and Lee’s Pharmaceutical Announce Publication of...

01/09/2011

Jennerex and Lee’s Pharmaceutical Announce the Publicatiion of...

01/09/2011

01/09/2011

01/09/2011

01/09/2011

01/09/2011

01/09/2011

03/08/2011

Jennerex and Lee’s Pharmaceutical Reports Positive Mechanistic...

01/08/2011

01/08/2011

01/08/2011

20/07/2011

Completed Last Patient Follow-up in Clinical Study on Acetyl...

30/05/2011

30/05/2011

23/05/2011

Jennerex and Lee’s Pharmaceutical Present Positive JX-594...

15/05/2011

15/05/2011

12/05/2011

Patients Enrollment completed in Clinical Study on Acetyl L-Carnitine...

09/05/2011

Lee’s Pharma Announced the New Drug Registration of Natulan® for...

18/04/2011

Lee’s Pharm Announced the Completion of Phase I Study for its...

13/04/2011

Patients Enrollment completed in Clinical Study on Propiverine...

10/04/2011

20/03/2011

04/03/2011

Powder Pharmaceuticals Incorporated Enters into Agreement with ...

14/02/2011

Propionyl-L-Carnitine Clinical Study Meets Primary and Secondary...

05/01/2011

Approval received to initiate clinical study for Trittico®

31/12/2010

30/12/2010

Lee’s Pharmaceutical Enters into Agreement with CID S.r.l. ...

06/12/2010

Lee’s Pharm Accredited “Hong Kong Outstanding Enterprises 2010”

29/10/2010

Grand Opening of Headquarters of Powder Pharmaceuticals

22/09/2010

Grand Opening of Powder Pharmaceuticals Incorporated

09/08/2010

09/08/2010

02/07/2010

UNITED THERAPEUTICS AND LEE’S PHARMACEUTICAL SIGN REMODULIN...

02/07/2010

Patients Enrollment completed in Clinical Study on Pro...

09/06/2010

Lee’s Pharm Accredited “Asia’s Best Companies 2010 – (China) Best...

07/06/2010

Best Small-cap Company

17/05/2010

Warm congratulations to the successful listing of Lee’s Pharm on the...

17/05/2010

Lee’s Pharmaceutical Trading Debut

24/04/2010

15/03/2010

RECORDATI AND LEESPHARM ANNOUNCE PARTNERSHIP FOR ZANIDIP® IN CHINA

29/01/2010

Obtained Registration Certificate for Medical Device of Veloderm® in...

15/01/2010

Obtained Renewal of Imported Drug License for Co-dergocrine Mesylate...

14/01/2010

Obtained Renewal of Imported Drug License for Ferplex® Iron...

31/12/2009

Distribution Agreement signed to market Lercanidipine tablets in...

28/12/2009

23/11/2009

JENNEREX AND LEE’S PHARMACEUTICALS ANNOUNCE PARTNERSHIP FOR JX-594 IN...

06/11/2009

Phase I Clinical Study on Antiplatelet Thrombolysin injection

15/10/2009

05/07/2009

28/06/2009

14/06/2009

31/05/2009

29/04/2009

20/03/2009

14/03/2009

08/03/2009

02/03/2009

Lee’s Pharmaceutical Enters into Agreement with Nippon Shinyaku...

28/02/2009

17/02/2009

17/02/2009

22/12/2008

Anhui Government Official Visited Zhaoke Pharmaceutical (Hefei) Co....

17/12/2008

Lee’s Pharmaceutical Establishes New R&D Centre at the...

13/12/2008

13/12/2008

12/12/2008

01/12/2008

01/12/2008

01/12/2008

29/11/2008

29/09/2008

28/08/2008

16/08/2008

18/07/2008

12/07/2008

22/06/2008

20/06/2008

14/06/2008

13/06/2008

06/06/2008

30/05/2008

28/05/2008

28/05/2008

28/05/2008

28/05/2008

23/05/2008

13/05/2008

New Drug Approval for Eyprotor® (Protein-free Calf Blood Extract...

09/05/2008

Testing en

09/05/2008

19/12/2007

LEE’S SIGNED COLLABORATION AGREEMENT WITH NOVELOS

20/09/2007

SIGMA-TAU STRENGTHENS ITS PARTICIPATION IN LEE’S PHARMACEUTICALS

09/08/2007

Exclusive Distribution Agreement Signed for Aloxi® injection in China

25/06/2007

Completed the Pharmacokinetic Study of HIBOR® (Bemiparin Sodium)

18/06/2007

Distribution Agreement Signed with Italfarmaco of Italy for...

15/06/2007

Important milestones achieved in Clinical Studies of Stent &...

18/10/2006

New Indication Approved for Cervicitis for Yallaferon

22/09/2006

Marketing Approval for Slounase® (Hemocoagulase) in China

23/06/2006

Approval to initiate a Clinical Trial for Hibor

20/02/2006

Approval for Clinical Study on Antiplatelet Thrombolysin injection

20/02/2006

Distribution agreement signed to market Propiverine Hydrochloride

20/12/2005

New Product Launch in Hong Kong – HIBOR® (Bemiparin Sodium)

20/12/2005

Completion of the Study of Yallaferon® in Cervicitis Patients

17/10/2005

New Drug Approval for Hemocoagulase snake venom

28/09/2005

Distribution of HORUS®S Coronary Stent

07/09/2005

New Indication Approved for Yallaferon®

15/06/2005

Distribution Agreement to market Somatostatin

08/06/2005

Complete patients recruitment for Cervicitis

09/05/2005

Completion of the Clinical Study of Eye-gel

29/03/2005

Market Isosorbide Mononitrate in HK and China

16/03/2005

Progress in Clinical Study of Eye-gel

04/02/2005

Good progress in Clinical Study in Cervicitis

0

0

0

0